Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes
Regression von Prädiabetes zu Normoglykämie und die Rolle kardiometabolischer Risikofaktoren für das spätere Risiko für Typ-2-Diabetes
Diabetologia · 2026-01 · 69 (1) · 69-80
DOI: 10.1007/s00125-025-06555-8 ↗Auf einen Blick
Bei Personen mit Prädiabetes war die Rückkehr zur Normoglykämie mit einem geringeren späteren Risiko für Typ-2-Diabetes verbunden. Besonders niedrige Risiken zeigten sich bei günstigen kardiometabolischen Profilen.
Fragestellung
Ist die Rückkehr zur Normoglykämie bei Prädiabetes mit einem geringeren Risiko für Typ-2-Diabetes verbunden, und verändert ein günstiges kardiometabolisches Profil diesen Zusammenhang?
Methode
Individuelle Daten aus prospektiven Kohorten aus den USA, Australien und Asien; 8.191 Personen mit Prädiabetes und mindestens 2 Nachbeobachtungen; Analyse mit hierarchischen Mixed-Effects-Proportional-Hazards-Weibull-Modellen.
Ergebnisse
Normoglykämie-Rückkehr war gegenüber persistierendem Prädiabetes mit 51 % geringerem Typ-2-Diabetes-Risiko verbunden. Zusätzliche günstige Profile zeigten noch niedrigere Risiken, z. B. bei Nichtraucher:innen, normalem BMI und normalem Blutdruck.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass die Priorisierung der Rückkehr zur Normoglykämie im Prädiabetes-Stadium in Leitlinien zur Senkung des Typ-2-Diabetes-Risikos beitragen könnte, besonders bei günstigen kardiometabolischen Profilen.
Kernaussagen
- Normoglykämie-Rückkehr: 51 % geringeres Typ-2-Diabetes-Risiko
- Niedrigere Risiken bei günstigen kardiometabolischen Profilen
- Gewichtsverlust plus Normoglykämie-Rückkehr war ebenfalls günstiger
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, online erschienen am 18.10.2025. Verfasst von Najmeh Davoodian und 19 weiteren Autor:innen. Beteiligte Einrichtung: IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine-Barwon Health, Faculty of Health, Deakin University,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Blood Glucose. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deakin University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/hypothesis We aimed to investigate the association between reversion to normoglycaemia among individuals with prediabetes (fasting plasma glucose 5.6–6.9 mmol/l in the absence of other criteria for type 2 diabetes) and the subsequent risk of type 2 diabetes, and to examine whether concurrent favourable cardiometabolic risk factor profiles modify this association.
Methods
We used individual-level data from prospective cohorts in the USA, Australia and Asia. Participants with prediabetes at baseline, with at least two follow-ups ( n =8191) at median intervals of 2.9 years (IQR 2.3–9.0) and 3.1 years (IQR 2.6–3.6), were classified into restoration of normoglycaemia and persistent prediabetes groups based on the glucose status at the first follow-up (normoglycaemia or prediabetes). Type 2 diabetes occurrence was assessed at subsequent follow-ups. Hierarchical mixed-effects proportional hazards Weibull models estimated type 2 diabetes risk, adjusting for age, sex and cardiometabolic risk factors. A subgroup analysis evaluated the combined association of normoglycaemia restoration and normal cardiometabolic risk factor levels on subsequent type 2 diabetes risk.
Results
In individuals with prediabetes, normoglycaemia restoration compared with persistent prediabetes was associated with a 51% lower risk of developing type 2 diabetes. Even lower risks were observed among individuals with concurrent favourable cardiometabolic profiles, including non-smokers (HR 0.20, 95% CI 0.10, 0.31), and those with normal BMI (0.16, 95% CI 0.06, 0.27), waist circumference (0.22, 95% CI 0.12, 0.33), waist-to-height ratio (0.15, 95% CI 0.03, 0.26), WHR (0.17, 95% CI 0.05, 0.28), and systolic (0.20, 95% CI 0.11, 0.30) and diastolic (0.25, 95% CI 0.12, 0.38) blood pressure, triacylglycerol (0.24, 95% CI 0.13, 0.35) and HDL-cholesterol levels (0.21, 95% CI 0.13, 0.29). Weight loss combined with normoglycaemia restoration was also associated with lower type 2 diabetes risk (0.18, 95% CI 0.07, 0.30) compared with weight gain and persistent prediabetes. Conclusions/interpretation Our results suggest that prioritising normoglycaemia restoration during the prediabetes stage in clinical guidelines may contribute to reducing the risk of type 2 diabetes, particularly when accompanied by favourable cardiometabolic health profiles. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine-Barwon Health, Faculty of Health, Deakin University, Geelong, VIC, Australia. n.davoodian@deakin.edu.au.
- IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine-Barwon Health, Faculty of Health, Deakin University, Geelong, VIC, Australia.
- Biostatistics Unit, Faculty of Health, Deakin University, Geelong, VIC, Australia.
- The George Institute for Global Health, University of New South Wales, Sydney, Australia.
- Faculty of Health, Deakin University, Melbourne, Australia.
- School of Population Health, Curtin University, Perth, Australia.
ORCID-Profile: Najmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, Crystal Man Ying Lee, Julie A Pasco, Robert J Adams, Fereidoun Azizi, Alain G Bertoni, Stephen Colagiuri, Edward W Gregg, Tiffany K Gill, Farzad Hadaegh, Davood Khalili, Dianna J Magliano, Morgana Mongraw-Chaffin, Gita D Mishra, Jonathan E Shaw, Masaru Sakurai, Hiroshi Yatsuya, Mohammadreza Mohebbi
Förderung
- Deakin University
Zitieren
APA
Davoodian, N., Lotfaliany, M., Huxley, R. R., Lee, C. M. Y., Pasco, J. A., Adams, R. J., Azizi, F., Bertoni, A. G., Colagiuri, S., Gregg, E. W., Gill, T. K., Hadaegh, F., Khalili, D., Magliano, D. J., Mongraw-Chaffin, M., Mishra, G. D., Shaw, J. E., Sakurai, M., Yatsuya, H., & Mohebbi, M. (2026). Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes. Diabetologia, 69(1), 69-80. https://doi.org/10.1007/s00125-025-06555-8
Vancouver
Davoodian N, Lotfaliany M, Huxley RR, Lee CMY, Pasco JA, Adams RJ, et al. Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes. Diabetologia. 2026;69(1):69-80. doi:10.1007/s00125-025-06555-8
BibTeX
@article{Davoodian2026,
author = {Davoodian, Najmeh and Lotfaliany, Mojtaba and Huxley, Rachel R and Lee, Crystal Man Ying and Pasco, Julie A and Adams, Robert J and Azizi, Fereidoun and Bertoni, Alain G and Colagiuri, Stephen and Gregg, Edward W and Gill, Tiffany K and Hadaegh, Farzad and Khalili, Davood and Magliano, Dianna J and Mongraw-Chaffin, Morgana and Mishra, Gita D and Shaw, Jonathan E and Sakurai, Masaru and Yatsuya, Hiroshi and Mohebbi, Mohammadreza},
title = {Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes},
journal = {Diabetologia},
year = {2026},
volume = {69},
number = {1},
pages = {69--80},
doi = {10.1007/s00125-025-06555-8}
}
EUVIMED